Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis

Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis

Abstract Background The CHOICES study randomized participants with HIV and opioid use disorder (OUD) to HIV clinic-based extended-release naltrexone (XR-NTX), which requires complete cessation of opioid use, versus treatment-as-usual (i.e., buprenorphine, methadone). Study participants randomized to...

Full description

Bibliographic Details
Main Authors: Kim A. Hoffman, Robin Baker, Laura C. Fanucchi, Paula J. Lum, Lynn E. Kunkel, Javier Ponce Terashima, Dennis McCarty, Petra Jacobs, P. Todd Korthuis
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Addiction Science & Clinical Practice
Subjects:
Extended-release naltrexone
Opioid withdrawal
Induction
Opioid use disorder
HIV
Online Access:https://doi.org/10.1186/s13722-021-00277-z

Internet

https://doi.org/10.1186/s13722-021-00277-z

Similar Items